Physician profile
Prem Patel
NPI 1376073684
$1,723.56
in general payments reported to CMS, 2019-2025
22 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $343 · 2023: $627 · 2024: $460 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048 · Education: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.72 |
| Education | $333.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $378.77 | 2022-2023 | Onyx Frontier |
| E.R. Squibb & Sons, L.L.C. | $296.29 | 2022-2024 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $198.00 | 2022-2024 | Brilinta |
| Boston Scientific Corporation | $98.81 | 2024-2025 | General - Therapies, General - Brady, Synergy |
| Ucb, INC. | $88.32 | 2023-2024 | Cimzia, Bimzelx |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Inari Medical, INC. | $82.26 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $75.59 | 2025 | Aveir |
| Pfizer INC. | $68.30 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $65.26 | 2024-2025 | |
| Shockwave Medical, INC | $56.63 | 2023-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $31.47 | 2024 | Impella |
| Chiesi USA, INC. | $27.09 | 2025 | Juxtapid |
| Terumo Medical Corporation | $26.31 | 2024 | Heartrail, Glidesheath Slender |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.87 | 2024 | Lifevest |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $20.44 | 2024 | Assure Wcd |
| Penumbra, INC. | $19.99 | 2024 | Indigo System |
| Dermavant Sciences, INC. | $19.63 | 2024 | Vtama |
| Abbvie INC. | $17.79 | 2023 | |
| Amgen INC. | $15.99 | 2025 | Repatha |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.63 | 2023 | Siliq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prem Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.